Dyadic announces collaboration to commercialize animal-free alternative proteins using dapibus™

Jupiter, fla., may 08, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products and alternative proteins for human and animal health, today announced that it entered into a co-development and marketing agreement with fermbox bio inc (“fermbox”).
DYAI Ratings Summary
DYAI Quant Ranking